Drug
Dolastatin 10 clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 1998
How studies write it
Studies that test it under each name
Name
- dolastatin 10
- 7
Studies by the year they started
7 studies that test it; most in 1999 (4)
| Year | Studies |
|---|---|
| 1998 | 3 |
| 1999 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 7
M.D. Anderson Cancer Center (2) · University of Chicago (1) · University of Vermont (1) · Barbara Ann Karmanos Cancer Institute (1) · National Cancer Institute (NCI) (1) · Mayo Clinic (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic Agents source
Studies
Open first, then newest update. How each study uses dolastatin 10 is read from its arms, and is right about nine times in ten.
Testing it · 7
- Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedPhase 1M.D. Anderson Cancer CenterNCT00003693Written as Dolastatin 10
- Dolastatin 10 in Treating Patients With Metastatic Pancreatic CancerCompletedPhase 2M.D. Anderson Cancer CenterNCT00003677Written as Dolastatin 10
- Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder CancerCompletedPhase 2University of ChicagoNCT00003557Written as dolastatin 10
- Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic LeukemiaCompletedPhase 2University of VermontNCT00005579Written as dolastatin 10
- Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone TherapyCompletedPhase 2Barbara Ann Karmanos Cancer InstituteNCT00003626Written as dolastatin 10
- Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaCompletedPhase 2National Cancer Institute (NCI)NCT00003778Written as dolastatin 10
- Dolastatin 10 in Treating Patients With Advanced Kidney CancerCompletedPhase 2Mayo ClinicNCT00003914Written as dolastatin 10
Codes
What other systems call dolastatin 10 · ClinicalTrials.gg INT003519
- MeSH (NLM) C064570dolastatin 10Confirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) EI946JT51XDOLASTATIN 10Confirmed FDA, NLM, Wikidata
- Wikidata Q27104943dolastatin 10Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C1300Dolastatin 10One source FDA
- DrugBank DB12730One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C064570 | dolastatin 10 | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | EI946JT51X | DOLASTATIN 10 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27104943 | dolastatin 10 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1300 | Dolastatin 10 | One source FDA |
| DrugBank | DB12730 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.